Go Pro

TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History

TransCode Therapeutics logo
$3.28 -0.20 (-5.75%)
Closing price 04:00 PM Eastern
Extended Trading
$3.42 +0.14 (+4.27%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransCode Therapeutics Stock Price Performance

The TransCode Therapeutics (RNAZ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.32%, with a year-to-date return of -51.98%. In the past month, the stock has decreased 61.77%, reflecting recent market activity.

As of the latest close, TransCode Therapeutics traded at $3.28 with a market cap of $3.48 million and volume of 40,808 shares. Five years ago, the stock traded at a split-adjusted price of $70,009,632.00, representing a 100.00% decrease over that period. At the time, it had a market cap of $34.35 million and a volume of 0 shares.

Receive RNAZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-17.17%
1 Month
Performance
-61.77%
3 Month
Performance
-52.70%
Year-To-Date
Performance
-51.98%
1 Year
Performance
-70.32%
5 Year
Performance
-100.00%

RNAZ Stock Chart for Friday, August, 14, 2026

TransCode Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/14/2026$3.48$3.28
-5.75%
$3.70$3.2140,808 shs$3.48 million
08/13/2026$3.37$3.48
+3.26%
$3.50$3.3023,139 shs$3.69 million
08/12/2026$3.43$3.37
-1.75%
$3.61$3.3218,077 shs$3.57 million
08/11/2026$3.88$3.43
-11.60%
$3.98$3.4323,060 shs$3.64 million
08/10/2026$3.96$3.88
-2.02%
$4.26$3.8819,985 shs$4.11 million
08/07/2026$4.27$3.96
-7.26%
$4.31$3.9627,490 shs$4.20 million
08/06/2026$4.25$4.27
+0.47%
$4.30$3.9913,365 shs$4.53 million
08/05/2026$4.45$4.25
-4.49%
$4.54$4.258,367 shs$4.51 million
08/04/2026$4.22$4.45
+5.45%
$4.72$4.3814,479 shs$4.72 million
08/03/2026$4.56$4.22
-7.46%
$4.62$4.229,335 shs$4.83 million
07/31/2026$5.25$4.56
-13.14%
$5.37$4.4729,998 shs$5.56 million
07/30/2026$4.96$5.25
+5.85%
$5.51$5.0010,347 shs$5.57 million
07/29/2026$4.94$4.96
+0.40%
$5.31$4.805,227 shs$5.26 million
07/28/2026$5.45$4.94
-9.36%
$6.00$4.5042,483 shs$5.23 million
07/27/2026$5.93$5.45
-8.09%
$6.13$5.4023,835 shs$5.78 million
07/24/2026$7.25$5.93
-18.21%
$6.69$5.8524,551 shs$6.29 million
07/23/2026$8.07$7.25
-10.18%
$7.97$7.2513,731 shs$7.69 million
07/22/2026$8.29$8.07
-2.68%
$8.97$8.0410,823 shs$7.67 million
07/21/2026$8.73$8.29
-4.99%
$8.97$8.0410,823 shs$7.88 million
07/20/2026$8.43$8.73
+3.56%
$8.88$8.4514,399 shs$8.29 million
07/17/2026$8.27$8.43
+1.93%
$8.99$8.125,739 shs$8.01 million
07/16/2026$8.69$8.27
-4.83%
$8.74$8.276,421 shs$7.86 million
07/15/2026$8.58$8.69
+1.28%
$9.40$8.4417,666 shs$8.26 million
07/14/2026$8.56$8.58
+0.23%
$8.65$8.0117,222 shs$8.15 million
07/13/2026$8.83$8.56
-3.06%
$9.12$7.9425,209 shs$8.13 million

This page (NASDAQ:RNAZ) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners